Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: An in vitro approach

Journal of Urology

Volumn 162, Issue 2, 1999, Pages 546-552

  Marti, A ^b   Lange, N ^b   Van Den Bergh, H ^b   Sedmera, D ^b   Jichlinski, P ^b   Kucera, P ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b NONE

Author keywords

Aminolevulinic acid; Cancer; In vitro; Photodynamic detection; Photodynamic therapy; Urinary bladder

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

ANIMAL TISSUE; ARTICLE; BLADDER CARCINOMA; BLADDER MUCOSA; CELL DESTRUCTION; CELL VIABILITY; HUMAN; HUMAN TISSUE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; UROTHELIUM;

EID: 0032879052     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68625-9     Document Type: Article

References (24)

1. Abel, P. D.: Follow-up of patient with superficial transitional cell carcinoma of the bladder: the case for a change in policy. Br. J. Urol., 72: 135, 1993.
2. Raghavan, D., Shipley, W. U., Garnick, M. B., Russell, P. J. and Richie, J. P.: Biology and management of bladder cancer. N. Engl. J. Med., 322: 1129, 1990.
3. Lamm, D. L.: BCG in perspectives: advances in the treatment of superficial bladder cancer. Eur. Urol., 27: 2, 1995.
4. Kennedy, J. C. and Pottier, R. H.: Endogenous protoporphyrin IX, a clinical useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol B: Biol., 14: 275, 1992.
5. Berg, K., Anholt, H., Beech, Ø. and Moan, J.: The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolevulinic acid-treated cells. Brit. J. Cancer, 74: 688, 1996.
6. Kennedy, J. C., Pottier, R. H. and Pross, D. C.: Photodynamic therapy with endogenous protoporphyrin IX; basic principles and present clinical experience. J. Photochem. Photobiol B: Biol., 6: 143, 1990.
7. Kriegmair, M., Baumgartner, R., Knüchel, R., Stepp, H. and Hofstädter, A.: Detection of early bladder cancer by 5-aminolevulinic acid induced Protoporphyrin fluorescence. J. Urol., 155: 105, 1996.
8. Jichlinski, P., Forrer, M., Mizeret, J., Glanzmann, T., Braichotte, G., Wagnière, G., Zimmer, G., Guillou, L., Schmidlin, F., Graber, P. and Leisinger, H. J.: Clinical evaluation of a method for detecting superficial transitional cell carcinoma of the bladder by light induced fluorescence of protoporphyrin IX following topical application of 5-aminolevulinic acid. Preliminary results. Lasers Surg. Med., 20: 402, 1997.
9. Steinbach, P., Kriegmair, M., Baumgartner, R., Hofstädter, F. and Knüchel, R.: Intravesical instillation of 5-aminolevulinic acid: the fluorescence metabolite is limited to the urothelial cells. Urology, 44: 676, 1994.
10. Potter, W. R., Mang, T. S. and Dougerthy, T. J.: The theory of photodynamic therapy dosimetry: consequences of photodestruction of sensitizer. Photochem. Photobiol. B: Biol., 46: 97, 1987.
11. Steinbach, P., Weingandt, H., Baumgartner, R., Kriegmair, M., Hofstädter, F. and Knüchel, R.: Cellular fluorescence of the endogenous photosensitizer protoporphyrin IX following exposure to 5-aminolevulinic acid. Photochem. Photobiol. B: Biol., 62: 887, 1995.
12. Jacob, W. J., Herschler, R. J. and Rosenbaum, E. E.: Dimethylsulfoxide (DMSO); laboratory and clinical evaluation. JAMA, 147: 1350, 1965.
13. Desgrandchamps, P., Moulinier, F., Cochand-Priollet, B., Wasserf, M., Teillac, P. and Le Duc, A.: Microscopic study of the pig ureteral urothelium. J. Urol, 157: 1926, 1997.
14. Kucera, P., Abriel, H. and Katz, U.: Ion transport across the early chick embryo: I. electrical measurements, ionic fluxes and regional heterogeneity. J. Membr. Biol., 141: 149, 1994.
15. de Kloek, J. and Beijersbergen van Henegouwen, G.: Prodrugs of 5- aminolevulinic acid for photodynamic therapy. Photochem. Photobiol. B: Biol., 64: ,1996.
16. Gaullier, J. M., Berg, K., Peng, Q., Anholt, H., Selbo, P. K., Ma, L. W. and Moan, J.: Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res., 57: 1481, 1997.
17. Haller, C., Schick, C. S., Zorn, M. and Kübler, W.: Cytotoxicity of radiocontrast agents on polarized renal epithelial cell monolayers. Cardiovasc. Res., 33: 655, 1996.
18. Hermes-Lima, M.: How do Ca 2+ and 5-aminolevulinic acid-derived oxyradicals promote injury to isolated mitochondria? Free Radic. Biol. Med., 19: 381, 1995.
19. Chang, S-C., Mac Robert, A. and Bown, S.: Biodistribution of protoporphyrin IX in rat urinary bladder after intravesical instillation of 5-aminolevulinic acid. J. Urol., 155: 1744, 1996.
20. Bachor, R., Reich, E., Rück, A. and Hautmann, R.: Aminolevulinic acid for photodynamic therapy of bladder carcinoma. Urol. Res., 24: 285, 1996.
21. Iinuma, S., Bachor, R., Flotte, T. and Hasan, T.: Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PPIX in an orthotopic rat bladder tumor model, J. Urol., 153: 802, 1995.
22. Rück, A., Köllner, H., Schneckenburger, H. and Steiner, R.: Competition between photobleaching and fluorescence increase of photosensitizing porphyrin and tetrasulphonated chloroaluminiumphtalocyanine. J. Photochem. Photobiol. B: Biol., 5: 311, 1990.
23. Cox, G. S., Bobillier, C. and Whitten, D. G.: Photo-oxidation and singlet oxygen sensitization by protoporphyrin IX and its photo-oxydation products. Photochem. Photobiol. B: Biol., 36: 401, 1982.
24. Lange, N., Jichlinski, P., Zellweger, M., Forrer, M., Marti, A., Kucera, P., Guillou, L., Wagnières, G. and Van den Bergh, H.: Photodetection of early human bladder cancer based on the fluorescence of 5-aminolevulinic acid hexyelester-induced protoporphyrin IX: a pilot study. British J. Canc., 1999.